Lynn Schuchter, MD, Oncology, Haverford, PA, Hospital of the University of Pennsylvania

LynnMSchuchterMD

Oncology Haverford, PA

Hematologic Oncology, Melanoma

Professor of Medicine, University Pennsylvania

Dr. Schuchter is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schuchter's full profile

Already have an account?

Summary

  • Dr. Lynn Schuchter is an oncologist in Haverford, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, and UPMC Presbyterian. She received her medical degree from Chicago Medical School at Rosalind Franklin University and has been in practice 35 years. She specializes in hematologic oncology and melanoma and is experienced in sarcomas, melanoma and cutaneous malignancies, and general medical oncology.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Medical Oncology, 1986 - 1989
  • Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1985 - 1986
  • Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
  • Chicago Medical School at Rosalind Franklin University
    Chicago Medical School at Rosalind Franklin UniversityClass of 1982

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1989 - 2022
  • MD State Medical License
    MD State Medical License 1986 - 1989
  • IL State Medical License
    IL State Medical License 1982 - 1987
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • Philadelphia Magazine Castle Connolly, 2005-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Integrating Machine Learning Mortality Estimates with Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients with Cancer  
    Ravi B Parikh, Justin E Bekelman, Lynn M Schuchter, Lawrence N Shulman, Mitesh S Patel, JAMA Oncology
  • Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients with Cancer  
    Lawrence N Shulman, Lynn M Schuchter, Mitesh S Patel, Ravi B Parikh, JAMA Oncology
  • Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response  
    Xiaowei Xu, Haidong Dong, Tara C Mitchell, Lynn M Schuchter, Alexander C Huang, Suzanne McGettigan, Wei Xu, Giorgos C Karakousis, Xiaoming Liu, Gordon Mills, Nature
  • Join now to see all

Press Mentions

  • Testing Cancer Patients for the Coronavirus
    Testing Cancer Patients for the CoronavirusMarch 28th, 2020
  • Penn Medicine to Name Melanoma Center After Longport's Tara Miller
    Penn Medicine to Name Melanoma Center After Longport's Tara MillerMay 6th, 2019
  • Penn Medicine Names Melanoma Center After Longport's Tara Miller
    Penn Medicine Names Melanoma Center After Longport's Tara MillerMay 6th, 2019
  • Join now to see all

Grant Support

  • Cellular Molecular Biologics In Clinical Cancer ResearchNational Cancer Institute2010–2011
  • Targeted Therapy For MelanomaNational Cancer Institute2004–2008
  • Targeted Therapy For MelanomaNational Cancer Institute2007
  • Upcc #1698 Injections Of B7 1 In Patients W/ Metastatic MelanomaNational Center For Research Resources1999–2002
  • Core--Clinical Research UnitNational Cancer Institute1996–2002
  • Clinical Application Of Adenovirus-Transduced, B7-Expressing Breast Cancer CellsNational Cancer Institute1996–1998
  • Phase II Study Of Bryostatin-1 In Patients With Metastatic MelanomaNational Center For Research Resources1996–1997
  • Genetically-Engineered Vaccine For Melanoma PatientsNational Cancer Institute1995–1997
  • Phase I Trial Of Ethyol And G-CSF With Dose Escalation Of Taxol In PatientsNational Center For Research Resources1996
  • Evaluation Of Interleukin-4 Therapeutic And Biological ENational Cancer Institute1990

Professional Memberships

Hospital Affiliations